DLBCL Europe

DLBCL Europe

Pharmaceutical Manufacturing

About us

DLBCL Europe helps European healthcare professionals learn more about diffuse large B-cell lymphoma (DLBCL). DLBCL is the most common form of non-Hodgkin lymphoma (a cancer of the lymphatic system).* View our social media guidelines here: http://bit.ly/2sV0H5W Reference * Freedman AS, Aster JC. Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma. Available at: https://www.uptodate.com/contents/epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-diffuse-large-b-cell-lymphoma; accessed June 2021.

Industry
Pharmaceutical Manufacturing
Company size
1,001-5,000 employees

Affiliated pages

Similar pages